School personnel information

写真b

MIZUKI Masao


Organization 【 display / non-display

  • 2000.04.01 - 2003.05.31, Division of Internal Medicine, Graduate School of Medicine, Research Assistant

  • 2003.06.01 - 2006.08.31, Division of Internal Medicine, Graduate School of Medicine, Associate Professor

  • 2006.09.01 - 2007.03.31, Osaka University Hospital, Associate Professor

  • 2007.04.01 - , Osaka University Hospital, Associate Professor

Education 【 display / non-display

Osaka University Faculty of Medicine  Graduated 1986.03

Research topics 【 display / non-display

  • Medical Oncology
    Hematology and medical oncology-related

 

Academic Papers 【 display / non-display

  • Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients., 2. Sata H, Shibayama H, Maeda I, Habuchi Y, Nakatani E, Fukushima K, Fujita J, Ezoe S, Tadokoro S, Maeda T, Mizuki M, Kosugi S, Nakagawa M, Ueda S, Iida M, Tokumine Y, Azenishi Y, Mitsui H, Oritani K, Kanakura Y., Experimental Haematology,43, 2015.05, Papers

  • The development history and future perspective of molecularly targeted therapy, Mizuki M, Kanakura Y,72 997-1003, 2014.06, Papers(In Japanese)

  • Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells., Fujita J, Mizuki M, Otsuka M, Ezoe S, Tanaka H, Satoh Y, Fukushima K, Tokunaga M, Matsumura I, Kanakura,136(1):61-73, 2011.04, Papers

  • Constitutively active FGFR3 with Lys650Glu mutation enhances bortezomib sensitivity in plasma cell malignancy., Otsuka M, Mizuki M, Fujita J, Kang S, Kanakura Y., Anticancer Research,31(1):113-22., 2011.01, Papers

  • Rolese of tyrosine residues 845, 892 and 922 in costitutive activation of murine FLT3 kinase domain, Ishiko J, Mizuki M, Matsumura I, Shibayama H, Sugahara H, Scholz G, Serve H, kanakura Y,24:8144-8153, 2005.12, Papers

display all >>

Books 【 display / non-display

  • Special, Gastrointestinal Stromal Tumor (GIST): From Pathology to Molecular Target Therapy/ KIT Mutations In Hematopoietic Malignancies, Masao Mizuki, Shuji Ueda, Itaru Matsumura, Jun Ishiko, Yuzuru Kanakura, Japan Scientific Societies Press, Karger, 2004.12